Abstract 4360664: A Case of Recurrent Acute Coronary Syndrome and Cardiogenic Shock due to Apolipoprotein A-IV Amyloidosis

Background: Amyloidosis occurs when endogenous circulating proteins misfold and are deposited in various tissues, including the myocardium. Apolipoprotein A-IV (Apo-AIV) amyloidosis is a rare form of this condition caused by deposition of amyloid proteins in the heart, kidney, and duodenum. Case Presentation: A 78-year-old male patient with coronary artery disease and prior ST elevation myocardial infarction, prior two vessel coronary artery bypass surgery, chronic systolic heart failure, and chronic kidney disease presented initially with dyspnea on exertion and angina concerning for myocardial infarction, with no culprit lesion identified on angiography. He underwent cardiac MRI and endomyocardial biopsy which was consistent with ApoAIV amyloidosis. He was readmitted with acute angina and extreme elevation in coronary biomarkers, but repeat coronary angiography again did not show a culprit lesion. Right heart catheterization revealed cardiogenic shock, and he required intra-aortic balloon pump support. Discussion: Cardiac amyloidosis commonly presents with diastolic heart failure and/or conduction abnormalities. ApoAIV amyloidosis is a rare form of amyloidosis whose clinical presentation is not very well characterized. This case highlights a rare manifestation of cardiac amyloidosis with acute coronary syndrome without changes in the epicardial coronary arteries. Instead, myocardial infarction was likely caused by microvascular coronary changes. Amyloidosis can less commonly cause obstruction of the coronary microvasculature which can lead to angina and ischemic changes as seen in this patient. Conclusion: ApoAIV amyloidosis is a rare form of cardiac amyloidosis. It is important to maintain a high index of suspicion for microvascular dysfunction and/or obstruction from amyloidosis that can lead to clinical syndromes of myocardial ischemia and infarction.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-03
DOI
https://doi.org/10.1161/circ.152.suppl_3.4360664
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4360664: A Case of Recurrent Acute Coronary Syndrome and Cardiogenic Shock due to Apolipoprotein A-IV Amyloidosis

Kevin A. Friede, Taylor Holmes, Rashmi Muthukkumar
Circulation
Amyloidosis: Diagnosis, Treatment, Outcomes
article

Abstract 4360664: A Case of Recurrent Acute Coronary Syndrome and Cardiogenic Shock due to Apolipoprotein A-IV Amyloidosis

Kevin A. Friede, Taylor Holmes, Rashmi Muthukkumar
article en

Abstract

Background: Amyloidosis occurs when endogenous circulating proteins misfold and are deposited in various tissues, including the myocardium. Apolipoprotein A-IV (Apo-AIV) amyloidosis is a rare form of this condition caused by deposition of amyloid proteins in the heart, kidney, and duodenum. Case Presentation: A 78-year-old male patient with coronary artery disease and prior ST elevation myocardial infarction, prior two vessel coronary artery bypass surgery, chronic systolic heart failure, and chronic kidney disease presented initially with dyspnea on exertion and angina concerning for myocardial infarction, with no culprit lesion identified on angiography. He underwent cardiac MRI and endomyocardial biopsy which was consistent with ApoAIV amyloidosis. He was readmitted with acute angina and extreme elevation in coronary biomarkers, but repeat coronary angiography again did not show a culprit lesion. Right heart catheterization revealed cardiogenic shock, and he required intra-aortic balloon pump support. Discussion: Cardiac amyloidosis commonly presents with diastolic heart failure and/or conduction abnormalities. ApoAIV amyloidosis is a rare form of amyloidosis whose clinical presentation is not very well characterized. This case highlights a rare manifestation of cardiac amyloidosis with acute coronary syndrome without changes in the epicardial coronary arteries. Instead, myocardial infarction was likely caused by microvascular coronary changes. Amyloidosis can less commonly cause obstruction of the coronary microvasculature which can lead to angina and ischemic changes as seen in this patient. Conclusion: ApoAIV amyloidosis is a rare form of cardiac amyloidosis. It is important to maintain a high index of suspicion for microvascular dysfunction and/or obstruction from amyloidosis that can lead to clinical syndromes of myocardial ischemia and infarction.

CirculationVol. 152(Suppl_3)
University of North Carolina at Chapel Hill (US), University of North Carolina Health Care (US)
Openalex Percentile: Top 71%
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.